Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | 5.0 |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 2.33 | 1.68 |
NAV | ₹13.18 | ₹207.80 |
Fund Started | 29 May 2023 | 20 Aug 2004 |
Fund Size | ₹482.56 Cr | ₹15687.54 Cr |
Exit Load | Exit load of 1%, if redeemed within 12 months. | Exit load of 1% if redeemed within 1 year |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 4.11% | 13.24% |
3 Year | - | 22.17% |
5 Year | - | 22.49% |
1 Year
3 Year
5 Year
Equity | 95.81% | 83.94% |
Cash | 4.19% | 15.74% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 5.64% |
ICICI Bank Ltd. | 4.94% |
Reliance Industries Ltd. | 4.86% |
Multi Commodity Exchange Of India Ltd. | 4.56% |
Wockhardt Ltd. | 4.31% |
Sun Pharmaceutical Industries Ltd. | 3.95% |
Tata Consultancy Services Ltd. | 3.82% |
ITC Ltd. | 3.70% |
Larsen & Toubro Ltd. | 3.58% |
Oracle Financial Services Software Ltd. | 3.47% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 9.18% |
HDFC Bank Ltd. | 8.88% |
Axis Bank Ltd. | 8.49% |
Maruti Suzuki India Ltd. | 4.90% |
SBI Life Insurance Company Ltd. | 4.26% |
Kotak Mahindra Bank Ltd. | 4.24% |
Cipla Ltd. | 3.96% |
Bharti Airtel Ltd. | 3.63% |
HCL Technologies Ltd. | 3.41% |
Piramal Pharma Ltd. | 3.12% |
Name | Dhimant Shah | Dhruv Muchhal |
Start Date | 01 Dec 2022 | 14 Sep 2023 |
Name
Start Date
Description | The scheme seek to generate long term capital appreciation by investing in a concentrated portfolio of equity & equity related instruments of upto 30 companies across market capitalization. | The scheme seeks to generate long term capital appreciation/income by investing in equity & equity related instruments of up to 30 companies. |
Launch Date | 29 May 2023 | 20 Aug 2004 |
Description
Launch Date